PCN82 Budget Impact Analysis of Subcutaneous Daratumumab for the Treatment of Patients with Multiple Myeloma in Sweden
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.219
https://www.valueinhealthjournal.com/article/S1098-3015(20)32475-X/fulltext
Title :
PCN82 Budget Impact Analysis of Subcutaneous Daratumumab for the Treatment of Patients with Multiple Myeloma in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32475-X&doi=10.1016/j.jval.2020.08.219
First page :
Section Title :
Open access? :
No
Section Order :
10170